Cargando…

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer

BACKGROUND: The aim of the study was to explore the treatment outcomes and prognostic factors for patients with previously irradiated but unresectable recurrent head and neck squamous cell carcinoma (rHNSCC) treated by stereotactic body radiotherapy (SBRT) plus cetuximab at a single institute in Tai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Tai-Lin, Chuang, Hui-Ching, Tsai, Ming-Hsien, Chien, Chih-Yen, Su, Yan-Ye, Lin, Yu-Tsai, Yang, Chao-Hui, Lai, Chi-Chih, Li, Shau-Hsuan, Fang, Fu-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661507/ https://www.ncbi.nlm.nih.gov/pubmed/34749016 http://dx.doi.org/10.1016/j.bj.2021.10.013

Ejemplares similares

Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer
por: Stanisce, Luke, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers
por: Anand, Anil Kumar, et al.
Publicado: (2020)

Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2020)

Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Quality of Life as a Mediator between Cancer Stage and Long-Term Mortality in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Radiotherapy
por: Liao, Kuan-Cho, et al.
Publicado: (2021)

Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy
por: Huang, Tai-Lin, et al.
Publicado: (2020)

Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients
por: Kurokawa, Marie, et al.
Publicado: (2015)

Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer
por: Wu, Ching-Nung, et al.
Publicado: (2017)

HyperArc VMAT stereotactic radiotherapy for locally recurrent previously‐irradiated head and neck cancers: Plan quality, treatment delivery accuracy, and efficiency
por: Pokhrel, Damodar, et al.
Publicado: (2022)

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
por: Chiu, Tai-Jan, et al.
Publicado: (2011)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Prognostic stratification of patients with AJCC 2018 pN1 disease in stage III oral squamous cell carcinoma
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Clinical significance of pretreatment prognostic nutritional index and lymphocyte-to-monocyte ratio in patients with advanced p16-negative oropharyngeal cancer—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2020)

Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer
por: Tseng, Wei-Ting, et al.
Publicado: (2019)

Prognostic Value of Pathologically Positive Nodal Number in p16-Negative Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma with pN3b Status
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

STEREOTACTIC RADIOTHERAPY FOR SPINAL INTRADURAL METASTASES DEVELOPING WITHIN OR ADJACENT TO THE PREVIOUS IRRADIATION FIELD – REPORT OF THREE CASES –
por: MORI, YOSHIMASA, et al.
Publicado: (2013)

The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation
por: Chuang, Hui-Ching, et al.
Publicado: (2020)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Patients of stage I oral cancer with pathologically low‐risk feature managed by primary tumor resection alone: Impact of depth of invasion and a nomogram analysis
por: Tsai, Ming‐Hsien, et al.
Publicado: (2022)

Prediction of Occult Contralateral Nodal Metastasis in Surgical Treated p16 Negative Oropharyngeal Squamous Cell Carcinoma
por: Huang, Hui-Shan, et al.
Publicado: (2022)

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy
por: Maahs, Lucas, et al.
Publicado: (2022)

Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma
por: Tai, Cheng-Jeng, et al.
Publicado: (2016)

Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer
por: Chen, Chang-Han, et al.
Publicado: (2015)

Infectious Complications in Head and Neck Cancer Patients Treated with Cetuximab: Propensity Score and Instrumental Variable Analysis
por: Lee, Ching-Chih, et al.
Publicado: (2012)

Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial
por: Cheng, Yu-Chen, et al.
Publicado: (2022)

Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer
por: Chuang, Hui-Ching, et al.
Publicado: (2022)

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
por: Okano, Susumu, et al.
Publicado: (2013)

Homologous platelet gel on radiation-induced dermatitis in a patient receiving head and neck radiotherapy plus cetuximab: A case report
por: Guberti, Monica, et al.
Publicado: (2023)

Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature
por: Kanakamedala, Madhava R, et al.
Publicado: (2010)

The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey
por: Krishnamurthy, Sapna, et al.
Publicado: (2022)

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
por: Bahig, Houda, et al.
Publicado: (2019)

Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Chen, Wei-Shan, et al.
Publicado: (2021)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
por: Hsu, Hung-Chih, et al.
Publicado: (2016)

Risk for surgical complications after previous stereotactic body radiotherapy of the spine
por: Roesch, Johannes, et al.
Publicado: (2017)

Radiotherapy plus cetuximab for locally advanced squamous cell head and neck cancer in patients with cisplatin-ineligible renal dysfunction: A retrospective study
por: Imai, Chiaki, et al.
Publicado: (2022)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020)

Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 for patients with dementia
por: Liu, Ting-Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ogroaq2mncrqiqitmek911hukr